Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
11/13/2003 | CA2484797A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway |
11/13/2003 | CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
11/13/2003 | CA2484551A1 Smart pro-drugs of serine protease inhibitors |
11/13/2003 | CA2484312A1 Catechin multimers as therapeutic drug delivery agents |
11/13/2003 | CA2484209A1 Protein kinase modulators and methods of use |
11/13/2003 | CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
11/13/2003 | CA2484065A1 Inhibitors of histone deacetylase |
11/13/2003 | CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
11/13/2003 | CA2483904A1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h-[1,2,4]-triazole for the treatment of autoimmune diseases |
11/13/2003 | CA2483865A1 7-aminoimidazotriazones |
11/13/2003 | CA2483846A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
11/13/2003 | CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
11/13/2003 | CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
11/13/2003 | CA2483787A1 Melanocortin receptor ligands |
11/13/2003 | CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
11/13/2003 | CA2483084A1 Tyrosine kinase inhibitors |
11/13/2003 | CA2482784A1 Composition for treating cancer containing n,n-dimethylphytosphingosine |
11/12/2003 | WO2003093219A1 NOVEL PHENYLETHANOLAMINE COMPOUNDS HAVING β2-ACCEPTOR EXCITATORY FUNCTION AND THEIR PREPARATION METHOD |
11/12/2003 | EP1361225A1 Compounds substituted with bicyclic amino groups |
11/12/2003 | EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels |
11/12/2003 | EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases |
11/12/2003 | EP1360959A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy |
11/12/2003 | EP1360500A2 Methods for selective targeting |
11/12/2003 | EP1360319A2 Diagnosis of diseases associated with metabolism |
11/12/2003 | EP1360299A2 The genome of a bifidobacterium |
11/12/2003 | EP1360295A2 Molecules for desease detection and treatment |
11/12/2003 | EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
11/12/2003 | EP1360189A1 Formulation of boronic acid compounds |
11/12/2003 | EP1360186A2 Carboline derivatives |
11/12/2003 | EP1360185A2 Carboline derivatives |
11/12/2003 | EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists |
11/12/2003 | EP1360178A2 Novel heterocyclic analogs of diphenylethylene compounds |
11/12/2003 | EP1360172A1 Ppar agonists |
11/12/2003 | EP1360170A1 Carboxylic amides, the production and use thereof as medicaments |
11/12/2003 | EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
11/12/2003 | EP1359927A1 Herbal pharmaceutical compositions for treating immunological disorders |
11/12/2003 | EP1359923A1 Use of selenite or preparations containing selenite for treating wounds |
11/12/2003 | EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
11/12/2003 | EP1359915A1 Urotensin-ii receptor antagonists |
11/12/2003 | EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
11/12/2003 | EP1282614B1 Hydroxamic acid derivatives |
11/12/2003 | EP1240164B1 Benzazole derivatives and their use as jnk modulators |
11/12/2003 | EP1206444B1 Compounds that inhibit tryptase activity |
11/12/2003 | EP1206265B1 Src kinase inhibitor compounds |
11/12/2003 | EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors |
11/12/2003 | EP1094815B1 Farnesyl protein transferase inhibitors for treating arthropathies |
11/12/2003 | EP0979087B1 Analgesic combination |
11/12/2003 | EP0897390B1 Human tumor necrosis factor delta and epsilon |
11/12/2003 | EP0861243B1 Heterocyclic compounds as bradykinin antagonists |
11/12/2003 | EP0759759B1 P75 tnf receptor promoters |
11/12/2003 | EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors |
11/12/2003 | EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications |
11/12/2003 | CN2586281Y Intelligent series charger |
11/12/2003 | CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
11/12/2003 | CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists |
11/12/2003 | CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof |
11/12/2003 | CN1455766A Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
11/12/2003 | CN1455691A Pharmaceutical compositions |
11/12/2003 | CN1455682A Compositions for gene therapy of rheumatoid arthritis including gene encoding anti-angiogenic protein or parts thereof |
11/12/2003 | CN1455676A Chinese-herb composition and method for preparing same |
11/12/2003 | CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine |
11/12/2003 | CN1455666A Externally-applicated chewing gum including chip-like center |
11/12/2003 | CN1455662A Dental care compositions |
11/12/2003 | CN1454659A Safflower oil |
11/12/2003 | CN1454652A Medicinal liquor for curing traumatic injury and rheumatalgia and preparing method thereof |
11/12/2003 | CN1454650A Medicine for curing cerebrovascular of retinal disease and rheumatism arthritis |
11/12/2003 | CN1454649A Exothermic therapeutic bag of Chinese herbal medicine and preparing method thereof |
11/12/2003 | CN1454648A Medicinal liquor for curing rheumatism and traumatic injuries |
11/12/2003 | CN1454645A External-use Chinese medicine preparation for wind-dispelling and dampness-removing and preparing method thereof |
11/12/2003 | CN1454632A Full gastrodia soft capsule and preparing method thereof |
11/12/2003 | CN1454631A Schefflera (Hantaoye) soft capsule and preparing method thereof |
11/12/2003 | CN1454625A Dampness-removing embolism-dissolving medicine |
11/12/2003 | CN1454624A Dampness-removing embolism-dissolving medicinal liquor |
11/12/2003 | CN1454610A Heat-clearing anti-inflammation drug |
11/12/2003 | CN1454607A Medicine for curing cervicitis and preparing method thereof |
11/12/2003 | CN1454605A Cough-relieving anti-inflammation drug |
11/12/2003 | CN1454601A Eye drops comprising liquaemin or potassium heparin and preparing method thereof |
11/12/2003 | CN1127512C Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides |
11/12/2003 | CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme |
11/12/2003 | CN1127487C Phthalazinone and its use, and drug containing same |
11/12/2003 | CN1127486C Phthalazine derivatives phosphodiesterase 4 inhibitors |
11/12/2003 | CN1127484C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
11/12/2003 | CN1127480C Colchicine derivative and its treatment use |
11/12/2003 | CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity |
11/12/2003 | CN1127350C Cyclosorin-containing soft capsule preparations |
11/11/2003 | US6646170 Intermediates for the synthesis of ether compounds |
11/11/2003 | US6646128 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives |
11/11/2003 | US6646108 Process for isolating IgG and IgA |
11/11/2003 | US6645999 Lactacystin analogs |
11/11/2003 | US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma |
11/11/2003 | US6645991 αvβ3 integrin inhibitors |
11/11/2003 | US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases |
11/11/2003 | US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors |
11/11/2003 | US6645986 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
11/11/2003 | US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors |
11/11/2003 | US6645976 Indolizine SPLA2inhibitors |
11/11/2003 | US6645970 Preventing T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer |
11/11/2003 | US6645955 3,6-dihydroxy-24-amidyl steroid derivatives |
11/11/2003 | US6645950 Benzimidazole vascular damaging agents |
11/11/2003 | US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound |